Tech Company Financing Transactions
SynapDx Funding Round
The Kraft Group participated in a funding round for SynapDx. The financing round was announced on 3/27/2013.
Transaction Overview
Company Name
Announced On
3/27/2013
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The funding will support the ongoing clinical development of SynapDx's breakthrough blood-based autism spectrum disorder (ASD) diagnostic test, designed to help clinicians identify children with autism earlier than they do today.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
4 Hartwell Pl.
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Website
Email Address
Overview
SynapDx was formed to develop and commercialize blood-based diagnostic tests for the early detection of autism.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stanley Lapidus
Chief Financial Officer
Bill Romeo
Browse more venture capital transactions:
Prev: 3/27/2013: EmiSense Technologies venture capital transaction
Next: 3/27/2013: Demandbase venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs